For Your Trading Desk
Trading Books

Price action, trading discipline, and the homework behind decisions made in seconds.

Click For Trade View

Sponsor Spike Success.

Unusual Put Options Activity in Merck Raises Questions About Stock Valuation

Aug 21, 2026
Unusual Put Options Activity in Merck Raises Questions About Stock Valuation

& Co., Inc. (MRK) has experienced a notable surge in its stock price, rising by 10.85% to $149.83 following the release of strong . However, this positive momentum is contrasted by an unusual spike in put options trading at a significantly lower strike price, raising questions about the stock's valuation.

On August 4, Merck reported strong revenue growth, particularly driven by its oncology drug portfolio. The company also announced successful results from a stage IV melanoma drug combination trial with Moderna, contributing to the stock's recent rise. Despite this, the trading of over 7,000 put contracts at a $135 strike price—almost 10% below the current price—has sparked speculation among investors.

For Your Trading Desk
Trading Journals
Click For Trade View
Financial Statements & Earnings Research
Click For Trade View

Sponsor Spike Success.

This unusual options activity, which is nearly 70 times the previous number of put contracts outstanding, suggests that some investors may be betting against the stock. Analysts have mixed views on Merck's valuation, with the average price target from 28 analysts surveyed being $137.73, indicating a potential decline from current levels.

Earnings per share (EPS) for Merck are projected to drop significantly this year, leading to a high expected price-to-earnings (P/E) ratio of over 54x. However, some analysts argue that this assessment may overlook the impact of one-time acquisition charges that have depressed EPS estimates. Without these charges, normalized EPS could be much higher, leading to a more favorable forward P/E ratio.

The potential for a dividend increase next quarter, consistent with Merck's historical performance, adds another layer to the valuation discussion. If the dividend rises to $3.63, the price target could drop to $123.47, suggesting a significant downside risk.

In conclusion, while the unusual activity indicates some investor skepticism about Merck's stock price, the company's strong fundamentals and potential for future growth may suggest that the stock is not as overvalued as some believe. Investors should carefully consider their positions, particularly in light of the current market dynamics.

For Your Trading Desk
Trading Books

Price action, trading discipline, and the homework behind decisions made in seconds.

Click For Trade View
Trading Journals

Log entries, exits, and the reason you clicked. 'It looked promising' deserves a second look.

Click For Trade View
Financial Statements & Earnings Research

References for reading earnings reports, cash flow, and balance sheets. The headline rarely brings all the footnotes.

Click For Trade View
Desk Accessories

Monitor stands and desk organizers for a trading setup with fewer loose ends.

Click For Trade View
Market Microstructure & Order Flow

Books on liquidity, order books, spreads, and trade execution. A closer look at what happens between clicking and getting filled.

Click For Trade View
Algorithmic Trading & Python

Coding and research books for systematic traders. Backtests deserve scrutiny, not a victory lap.

Click For Trade View

Sponsor Spike Success.

Across our publications

In Other News

Latest stories from other publications.

Explore all publications (opens in a new tab)